
Shinpoong Pharm secures European patent for Pyramax as Covid-19 treatment
Shinpoong Pharmaceutical said Tuesday that it received a decision from the European Patent Office (EPO) to grant a patent for Pyramax (pyronaridine phosphate-artesunate), which was approved for treating malaria last Friday. The patent is titled “ …